PRRT2 and neoplasm: This selectivity is underscored by studies demonstrating that PKCθ‐knockout mice exhibit tolerance to allergic reactions, autoimmune diseases, and allogeneic immune rejection, while remarkably retaining intact protective immunity against bacterial, viral, and tumor challenges [178].